Registration number:
Analytico Holdings Limited
for the Year Ended 31 December 2024
Analytico Holdings Limited
Contents
|
Company Information |
|
|
Statement of Financial Position |
|
|
Notes to the Financial Statements |
Analytico Holdings Limited
Company Information
|
Director |
Dr Neville Boon |
|
Registered office |
|
|
Accountants |
|
Analytico Holdings Limited
(Registration number: 13726522)
Statement of Financial Position as at 31 December 2024
|
Note |
2024 |
2023 |
|
|
Non-current assets |
|||
|
Investments |
|
|
|
|
Current assets |
|||
|
Receivables |
|
|
|
|
Net assets |
|
|
|
|
Equity |
|||
|
Called up share capital |
|
|
|
|
Shareholders' funds |
|
|
For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
The financial statements of Analytico Holdings Limited were approved and authorised for issue by the
.........................................
Director
Analytico Holdings Limited
Notes to the Financial Statements
for the Year Ended 31 December 2024
|
General information |
Analytico Holdings Limited (the 'company') is a private company limited by share capital, registered in England and Wales under the Companies Act. The address of the registered office is given on page 1. The nature of the company’s operations and its principal activities are set out in the directors' report on page 2.
|
Accounting policies |
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
The functional currency of the company is considered to be pound sterling (£) because that is the currency of the primary economic environment in which the company operates. The financial statements are presented in pound sterling (£).
Summary of disclosure exemptions
The company meets the definition of a qualifying entity under FRS 102 and has therefore taken advantage of the disclosure exemptions available to it in respect of its separate financial statements. The company is consolidated in the financial statements of its parent, XXX AB, which may be obtained from www.itiviti.com/financial-information/annual-reports OR XXXX, XXXX, Stockholm, SE1144, Sweden.. Exemptions have been taken in these separate company financial statements in relation to financial instruments, presentation of a cash flow statement, transactions with group entities and remuneration of key management personnel..
Going concern
Critical judgements and key sources of estimation uncertainties
There were no key sources of estimation uncertainties or critical judgements made by the directors in the process of applying the company’s accounting policies with significant effect on the amounts recognised in the financial statements.
Analytico Holdings Limited
Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)
|
2 |
Accounting policies (continued) |
Business combinations
Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.
Investments
Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.
Receivables
Receivables are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Receivables are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of receivables is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Financial instruments
Analytico Holdings Limited
Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)
|
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
|
Investments |
|
2024 |
2023 |
|
|
Investments in subsidiaries |
|
|
|
Subsidiaries |
£ |
|
Cost |
|
|
At 1 January 2024 |
|
|
Carrying amount |
|
|
At 31 December 2024 |
|
|
At 31 December 2023 |
|
Analytico Holdings Ltd owns 100% shares of Analytico Ltd
|
Receivables |
|
2024 |
2023 |
|
|
Other receivables |
|
|
|
|
|
|
Share capital and reserves |
Allotted, called up and fully paid shares
|
2024 |
2023 |
|||
|
No. |
£ |
No. |
£ |
|
|
Ordinary shares of £1 each |
120 |
120 |
120 |
120 |
|
Ordinary A shares of £1 each |
80 |
80 |
80 |
80 |
|
|
|
|
|
|